SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Genetech’s Oncology Boss Jumps Ship to Helm Bellicum
Business
Genentech’s Oncology Boss Jumps Ship to Helm Bellicum
January 31, 2017
 · 
3 min read
Genentech Grows on Promise of 70+ Drug Approvals
Policy
Genentech Dealt a Blow From Massachusetts’ Highest Court
January 16, 2017
 · 
3 min read
Genentech Grows on Promise of 70+ Drug Approvals
Policy
Beware: Rapes Alleged at Genentech by Janitorial Contractor
December 22, 2016
 · 
3 min read
Genentech Grows on Promise of 70+ Drug Approvals
Business
Meet the Man Who Was Just Named Genentech’s New CEO
December 15, 2016
 · 
2 min read
Meet 7 Bay Area Scientists Changing the Face of Biotech
Job Trends
With Bristol-Myers Squibb, Genentech and Merck & Co. Expanding in the Bay Area, Some Wonder if the Real Estate Boom is Too Much
November 14, 2016
 · 
2 min read
Genentech Grows on Promise of 70+ Drug Approvals
Job Trends
Genentech Snaps Up Four Buildings it Had Been Leasing Since 2006
November 10, 2016
 · 
2 min read
With New Owners, Ambrx, Inc. Aims To Challenge Genentech
November 3, 2016
 · 
1 min read
Genentech Grows on Promise of 70+ Drug Approvals
Business
Meet the Cancer Scientist Leading Genentech’s First Podcast
October 25, 2016
 · 
2 min read
FDA
Genentech’s Tecentriq Wins Second Approval of the Year, This Time for Lung Cancer
October 19, 2016
 · 
11 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Phase III Study Shows Genentech’s Actemra (Tocilizumab) Maintained Steroid-Free Remission In People With Giant Cell Arteritis (GCA)
June 6, 2016
 · 
6 min read
Drug Development
Genentech’s Arthritis Med Actemra Successful In Late-Stage Study in Rare Artery Inflammation
June 6, 2016
 · 
7 min read
Business
Evotec AG Extends Integrated Drug Discovery Alliance With Genentech
May 24, 2016
 · 
3 min read
Policy
Another Healthcare Provider Accuses Genentech of Fudging the Amount of Herceptin in Each Vial
May 23, 2016
 · 
1 min read
Drug Development
Phase III Study Of Genentech’s Alecensa (Alectinib) Showed Superior Efficacy Versus Crizotinib In Japanese People With A Specific Type Of Lung Cancer
May 19, 2016
 · 
8 min read
Pharm Country
Stand Up To Cancer And Genentech Join Forces Through “Be The Breakthrough” Campaign
May 4, 2016
 · 
4 min read
Drug Development
Genentech Highlights Personalized Medicines And Cancer Immunotherapies At 2016 ASCO Annual Meeting
May 3, 2016
 · 
1 min read
Drug Development
Genentech To Present New Data At American Academy of Neurology Showing Superior Efficacy Of Investigational Medicine Ocrelizumab Versus Comparators On Disease Activity And Progression In Two Forms Of Multiple Sclerosis
April 13, 2016
 · 
8 min read
FDA
Genentech Announces FDA Grants Venclexta (Venetoclax) Accelerated Approval For People With A Hard-To-Treat Type Of Chronic Lymphocytic Leukemia
April 12, 2016
 · 
11 min read
FDA
FDA Green Lights AbbVie, Genentech’s New Chronic Lymphocytic Leukemia Drug Venclexta
April 11, 2016
 · 
3 min read
Load More